Free Trial

Vise Technologies Inc. Acquires New Stake in Mettler-Toledo International Inc. (NYSE:MTD)

Mettler-Toledo International logo with Medical background

Vise Technologies Inc. purchased a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 247 shares of the medical instruments supplier's stock, valued at approximately $302,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. JPMorgan Chase & Co. raised its stake in shares of Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock valued at $332,634,000 after acquiring an additional 28,478 shares during the last quarter. Allworth Financial LP raised its stake in shares of Mettler-Toledo International by 367.4% in the fourth quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock valued at $285,000 after acquiring an additional 169 shares during the last quarter. Robeco Institutional Asset Management B.V. raised its stake in shares of Mettler-Toledo International by 18.0% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier's stock valued at $42,058,000 after acquiring an additional 5,234 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. raised its stake in shares of Mettler-Toledo International by 773.3% in the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 5,336 shares of the medical instruments supplier's stock valued at $6,530,000 after acquiring an additional 4,725 shares during the last quarter. Finally, Impax Asset Management Group plc raised its position in Mettler-Toledo International by 5.8% in the 4th quarter. Impax Asset Management Group plc now owns 198,852 shares of the medical instruments supplier's stock worth $243,331,000 after purchasing an additional 10,830 shares during the last quarter. Institutional investors own 95.07% of the company's stock.

Insider Activity

In other news, Director Michael A. Kelly sold 1,062 shares of the business's stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the transaction, the director now owns 120 shares of the company's stock, valued at $139,191.60. The trade was a 89.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.94% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

MTD has been the subject of several research analyst reports. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective for the company in a research report on Monday, April 7th. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and dropped their price objective for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Evercore ISI boosted their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research report on Monday, February 10th. Wall Street Zen cut shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. Finally, Wells Fargo & Company boosted their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research report on Monday, May 5th. Seven analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Mettler-Toledo International has a consensus rating of "Hold" and a consensus target price of $1,302.11.

Read Our Latest Stock Report on Mettler-Toledo International

Mettler-Toledo International Stock Performance

MTD traded down $16.85 during trading on Friday, reaching $1,156.33. 317,154 shares of the company's stock were exchanged, compared to its average volume of 150,673. The company's fifty day moving average price is $1,093.82 and its 200-day moving average price is $1,206.12. Mettler-Toledo International Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93. The firm has a market capitalization of $24.03 billion, a PE ratio of 28.53, a P/E/G ratio of 3.30 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, topping analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The firm had revenue of $883.74 million during the quarter, compared to analyst estimates of $876.61 million. During the same quarter in the previous year, the business earned $8.89 EPS. The business's quarterly revenue was down 4.6% compared to the same quarter last year. Research analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Further Reading

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Should You Invest $1,000 in Mettler-Toledo International Right Now?

Before you consider Mettler-Toledo International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.

While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines